Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane

Laryngoscope

Volumn 116, Issue 1, 2006, Pages 140-143

  Üneri, Cüneyd ^a   Sari, Murat ^b   Akboǧa, Jülide ^a   Yüksel, Meral ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b School of Pharmacy ^*

Author keywords

Free radicals; Rats; Ventilation tube; Vitamin E coating

Indexed keywords

ALPHA TOCOPHEROL; FREE RADICAL; REACTIVE OXYGEN METABOLITE; BIOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EARDRUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SILASTIC TUBE; TYMPANOSTOMY TUBE; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; INSTRUMENTATION; METABOLISM; METHODOLOGY; MIDDLE EAR VENTILATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROBABILITY; RANDOMIZATION; REFERENCE VALUE; RISK FACTOR; SCLEROSIS; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; MALE; MIDDLE EAR VENTILATION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; RISK FACTORS; SCLEROSIS; SENSITIVITY AND SPECIFICITY; TYMPANIC MEMBRANE; VITAMIN E;

EID: 33645236554     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000191460.32862.bf     Document Type: Article

References (15)

1. Kay D, Nelson M, Rosenfeld R. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg 2001;124:374-380.
2. Koç A, Uneri C. Sex distribution in children with tympanosclerosis after insertion of a tympanoplasty tube. Eur Arch Otorhinolaryngol 2002;258:16-19.
3. Koç A, Uneri C. Genetic predisposition for tympanosclerotic degeneration. Eur Arch Otorhinolaryngol 2002;259:180-183.
4. Polat S, Öztürk Ö, Üneri Ü, et al. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin e treatment. Laryngoscope 2004;114:720-725.
5. Mattsson C, Magnuson K, Hellström S. Myringotomy: a prerequisite for the development of myringosclerosis. Laryngoscope 1998;108:102-106.
6. Mattson C, Marklund SL, Hellström S. Application of oxygen free radical scavengers to diminish the occurence of myringosclerosis. Ann Otol Rhinol Laryngol 1997;106:513-518.
7. Spratley JE, Hellström S, Mattson C, et al. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. Ann Otol Rhinol Laryngol 2001;110:585-591.
8. Özcan C, Görür K, Cinel L, et al. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 2002;63:179-184.
9. Görür K, Özcan C, Polat A, et al. The anti-oxidant and anti-apoptotic activities of selenium in the prevention of myringosclerosis in rats. J Laryngol Otol 2002;116:426-429.
10. Mattson C, Magnuson K, Hellström S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Ann Otol Rhinol Laryngol 1995;104:625-632.
11. Dingle AF, Flood LM, Kumar BU, et al. The mini-grommet and tympanosclerosis: results at two years. J Laryngol Otol 1993;107:108-110.
12. Kinnari TJ, Rihkanen H, Laine T, et al. Albumin-coated tympanostomy tubes: prospective, double-blind clinical study. Laryngoscope 2004;114:2038-2043.
13. Gourin CG, Hubbell RN. Otorrhea after insertion of silver oxide-impregnated silastic tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1999;125:446-450.
14. Clermont G, Lecour S, Cabanne JF, et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med 2001;31:233-241.
15. Mattson C, Johansson C, Hellström S. Myringosclerosis develops within 9h of myringotomy. ORL J Otorhinolaryngol Relat Spec 1999;61:31-36.